SYNMOSA BIOPHARMA CORPORATION

SYNMOSA BIOPHARMA CORP. was founded in November, 2009 and headquartered in Taipei City. SYNMOSA BIOPHARMA CORP. has four major independent operating divisions: (1) Supply Chain Division, which provides drugs and medical device distribution services; (2) Material R&D Division, which engages in management of research and development of generic drugs and cosmeceutical ingredients; (3) Pharmaceutical Division, which is engaged in the manufacture of generic drugs and nutritional supplements; and (4) Sales & Marketing Division, which is engaged in the sales and marketing of products manufactured by the Company or those produced by third parties and sale of medical devices in the People's Republic of China. The Company's products principally include pharmaceuticals, nutritional supplements, medical devices, and cosmetics OEM/ODM. The Company distributes branded and generic drugs of third parties, as well as its own products. The Company focuses on the distribution and sales of pharmaceuticals for the general public market and health insurance market in Taiwan. The Supply Chain Division distributes a range of generic prescription and over-the-counter drugs, as well as topical drugs, injectables, and medical devices in various dosages and applications. These products are primarily used in hospitals, clinics, health centers, and retail pharmacies. The Material R&D Division is dedicated to the research and development, and marketing of generic chemical drugs, biologics, and cosmeceutical ingredients. The Pharmaceutical Division is engaged in the manufacture of chemicals, pharmaceuticals, medical devices, and cosmetics.

Wholesale Trade; Pharmaceutical and Medicine Manufacturing; Drugs and Druggists' Sundries Merchant Wholesalers; Chemical Manufacturing; Manufacturing

Wholesale Trade-Durable Goods; Wholesale Trade-Nondurable Goods; Pharmaceutical Preparations; Drugs, Proprietaries, and Sundries; Chemicals and Allied Products; Manufacturing

$141.56M